Stephen Hays
Stephen Hays
#77 - Central Nervous System Drug Development with Industry Expert Dr. Errol De Souza (Chairman @Bionomics)
#77 - Central Nervous System Drug Development with Industry Expert Dr. Errol De Souza (Chairman @Bionomics)
#77 - Central Nervous System Drug Development with Industry Expert Dr. Errol De Souza (Chairman @Bionomics)
Monday 15th February 2021
Join Stephen Hays and Dr. Errol De Souza as they discuss innovative drug development for mental health disorders on Stigma Podcast.
48 minutes
Informative
Engaging
Transformative
Educational
Thought-provoking
About this podcast
Author:
Stephen Hays
Overview:
Categories:
Body & Mind
Mindful Recovery
Mindfulness & Technology in Health
Innovative Treatments & Recovery Paths
Sexual Stigmas & Myths
Links:
Visit site
Episodes:
91 (View all)
Do you want to link to this podcast?
Get the buttons here!Dr. Errol De Souza: Pioneering New Treatments for Mental Health Disorders
Stay tuned, because that's really the value driving aspects in terms of where we could be thinking about taking Bnc210.
Ever wondered what goes into developing groundbreaking drugs for mental health and neurological disorders? In this episode, Stephen Hays sits down with Dr. Errol De Souza, the Executive Chairman of Bionomics, to discuss their innovative work in this field. Bionomics recently secured nearly $16 million to fund clinical trials for a promising new PTSD treatment. Dr. De Souza, a veteran in the biotech industry, brings a wealth of experience to the table.
He's raised hundreds of millions in capital, taken companies public, and sold others, all while focusing on Central Nervous System (CNS) disorders. Throughout his career, Dr. De Souza has held high-ranking roles in research and development at major companies like Aventis and Neurocrine Biosciences. He’s also served on the boards of several public and private companies, lending his expertise to shape the future of biotech.
In this chat, he breaks down the complex process of identifying small molecule therapeutics and testing their efficacy in animal models. But it’s not just about the science. The conversation also dives into the regulatory landscape and what it takes to invest in the biotech space. Dr. De Souza offers insights into the potential treatments for cognitive deficits and other mental health challenges.
If you're curious about the future of mental health treatments or have a keen interest in biotech innovations, this episode is a must-listen. Dr. De Souza’s expertise and passion make this an engaging and informative discussion.